These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Novel mononuclear Cu (II) terpyridine complexes: Impact of fused ring thiophene and thiazole head groups towards DNA/BSA interaction, cleavage and antiproliferative activity on HepG2 and triple negative CAL-51 cell line. Manikandamathavan VM; Thangaraj M; Weyhermuller T; Parameswari RP; Punitha V; Murthy NN; Nair BU Eur J Med Chem; 2017 Jul; 135():434-446. PubMed ID: 28475971 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, DNA/HSA Interaction Spectroscopic Studies and In Vitro Cytotoxicity of a New Mixed Ligand Cu(II) Complex. Gan Q; Fu X; Chen W; Xiong Y; Fu Y; Chen S; Le X J Fluoresc; 2016 May; 26(3):905-18. PubMed ID: 26961845 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action. Khan S; Malla AM; Zafar A; Naseem I PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes. Li GY; Du KJ; Wang JQ; Liang JW; Kou JF; Hou XJ; Ji LN; Chao H J Inorg Biochem; 2013 Feb; 119():43-53. PubMed ID: 23186647 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and crystal structure of new dicopper(II) complexes having asymmetric N,N'-bis(substituted)oxamides with DNA/protein binding ability: In vitro anticancer activity and molecular docking studies. Zheng K; Zhu L; Li YT; Wu ZY; Yan CW J Photochem Photobiol B; 2015 Aug; 149():129-42. PubMed ID: 26057022 [TBL] [Abstract][Full Text] [Related]
28. Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism. Qi YY; Gan Q; Liu YX; Xiong YH; Mao ZW; Le XY Eur J Med Chem; 2018 Jun; 154():220-232. PubMed ID: 29803995 [TBL] [Abstract][Full Text] [Related]
29. Cu(ii) and V(iv)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-l-alanines reveal promising anticancer therapeutic potential. Ribeiro N; Bulut I; Cevatemre B; Teixeira C; Yildizhan Y; André V; Adão P; Pessoa JC; Acilan C; Correia I Dalton Trans; 2021 Jan; 50(1):157-169. PubMed ID: 33290472 [TBL] [Abstract][Full Text] [Related]
30. Water-soluble DNA minor groove binders as potential chemotherapeutic agents: synthesis, characterization, DNA binding and cleavage, antioxidation, cytotoxicity and HSA interactions. Fu XB; Liu DD; Lin Y; Hu W; Mao ZW; Le XY Dalton Trans; 2014 Jun; 43(23):8721-37. PubMed ID: 24770345 [TBL] [Abstract][Full Text] [Related]
31. Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine. Li L; Du K; Wang Y; Jia H; Hou X; Chao H; Ji L Dalton Trans; 2013 Aug; 42(32):11576-88. PubMed ID: 23843095 [TBL] [Abstract][Full Text] [Related]
32. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study. Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692 [TBL] [Abstract][Full Text] [Related]
33. Cu(II) complexes with a salicylaldehyde derivative and α-diimines as co-ligands: synthesis, characterization, biological activity. Experimental and theoretical approach. Selaković S; Rodić MV; Novaković I; Matić IZ; Stanojković T; Pirković A; Živković L; Spremo-Potparević B; Milčić M; Medaković V; Dimiza F; Psomas G; Anđelković K; Šumar-Ristović M Dalton Trans; 2024 Feb; 53(6):2770-2788. PubMed ID: 38226867 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes. Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH). Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543 [TBL] [Abstract][Full Text] [Related]
36. Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin. Gou Y; Zhang Y; Qi J; Zhou Z; Yang F; Liang H J Inorg Biochem; 2015 Mar; 144():47-55. PubMed ID: 25573806 [TBL] [Abstract][Full Text] [Related]
37. The X-ray crystal structures, molecular docking and biological activities of two novel Cu(II) and Zn(II) complexes with a ligand having a potentially N Fatemikia H; Keypour H; Zeynali H; Karamian R; Ranjbar N; Gable RW J Inorg Biochem; 2022 Oct; 235():111910. PubMed ID: 35792371 [TBL] [Abstract][Full Text] [Related]
39. Relationship between the antiproliferative properties of Cu(II) complexes with the Schiff base derived from pyridine-2-carboxaldehyde and 5,6-diamino-1,3-dimethyluracil and the redox status mediated by antioxidant defense systems on glioma tumoral cells. Illán-Cabeza NA; Jiménez-Pulido SB; Hueso-Ureña F; Ramírez-Expósito MJ; Martínez-Martos JM; Moreno-Carretero MN J Inorg Biochem; 2020 Jun; 207():111053. PubMed ID: 32193050 [TBL] [Abstract][Full Text] [Related]
40. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies. Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]